{"id":"https://openalex.org/W2550848212","doi":"https://doi.org/10.1182/blood.v126.23.1824.1824","title":"Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy","display_name":"Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2550848212","doi":"https://doi.org/10.1182/blood.v126.23.1824.1824","mag":"2550848212"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.1824.1824","doi":"https://doi.org/10.1182/blood.v126.23.1824.1824","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1824.1824","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085487269","display_name":"Sonali C. Panchabhai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonali Panchabhai","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037671574","display_name":"Ilana Miriam Schlam","orcid":"https://orcid.org/0000-0003-4996-0400","observed_orcids":["https://orcid.org/0000-0003-4996-0400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ilana Miriam Schlam","raw_affiliation_strings":["Collaborative Research Building, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Collaborative Research Building, Scottsdale, AZ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078236354","display_name":"Sinto Sebastian Chirackal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sinto Sebastian Chirackal","raw_affiliation_strings":["Haematology and Oncology, Mayo Clinic, Scottsale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology and Oncology, Mayo Clinic, Scottsale, AZ","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003015868","display_name":"Rafa\u00ebl Fonseca","orcid":"https://orcid.org/0000-0002-5938-3769","observed_orcids":["https://orcid.org/0000-0002-5938-3769"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rafael Fonseca","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078236354"],"corresponding_institution_ids":["https://openalex.org/I4210125099"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27774661,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"1824","last_page":"1824"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11924","display_name":"Polyamine Metabolism and Applications","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ornithine-decarboxylase","display_name":"ornithine decarboxylase","score":0.9549999833106995},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.9110000133514404},{"id":"https://openalex.org/keywords/difluoromethylornithine","display_name":"difluoromethylornithine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/polyamine-biosynthesis","display_name":"polyamine biosynthesis","score":0.8339999914169312},{"id":"https://openalex.org/keywords/ras-signaling","display_name":"Ras signaling","score":0.7870000004768372},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.9670000076293945},{"id":"https://openalex.org/keywords/maf","display_name":"MAF","score":0.42500001192092896},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C2777250017","wikidata":"https://www.wikidata.org/wiki/Q458138","display_name":"Monoclonal gammopathy of undetermined significance","level":5,"score":0.7840595245361328},{"id":"https://openalex.org/C121289238","wikidata":"https://www.wikidata.org/wiki/Q931579","display_name":"Ornithine decarboxylase","level":3,"score":0.7471625804901123},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6970047950744629},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.588641345500946},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5619978308677673},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42601048946380615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40664222836494446},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3813250958919525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34176313877105713},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.2559773921966553},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.13907429575920105},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.1824.1824","doi":"https://doi.org/10.1182/blood.v126.23.1824.1824","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1824.1824","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2345972527","https://openalex.org/W2120553654","https://openalex.org/W7098316685","https://openalex.org/W2027003351","https://openalex.org/W2095919371","https://openalex.org/W2146355999","https://openalex.org/W2072095550","https://openalex.org/W2407529036","https://openalex.org/W2564201058","https://openalex.org/W2299209991"],"abstract_inverted_index":{"Abstract":[0],"Multiple":[1],"myeloma":[2],"(MM)":[3],"is":[4,27,42,89,118,124,141,249,362,474],"an":[5,555,573,591,609,628,646,664,682,699],"age":[6],"dependent":[7],"second":[8],"most":[9],"common":[10,29,149],"hematopoietic":[11],"malignancy":[12],"which":[13,131,146,212,248,361,445],"remains":[14],"incurable":[15],"despite":[16],"recent":[17],"advances":[18],"in":[19,44,54,78,115,157,166,176,191,206,225,264,273,321,400,413,454,476,531],"therapies.":[20],"Monoclonal":[21],"gammopathy":[22],"of":[23,38,40,46,74,129,144,152,184,306,342,367,381,411,498,558,576,594,612,631,649,667,685,702],"undetermined":[24],"significance":[25],"(MGUS)":[26],"a":[28,85,90,95,106,164,250,350,404,447,525,541],"premalignant":[30],"condition":[31],"that":[32,443],"precedes":[33],"MM.":[34,47,158,200,532],"Dysregulation":[35],"and":[36,56,61,82,135,218,277,282,309,318,386,402,423,461,485,501,528],"mutations":[37,64],"myriad":[39],"molecules":[41,114],"implicated":[43],"pathogenesis":[45],"Cyclins":[48],"(CCND)":[49],"are":[50,65,458],"almost":[51],"universally":[52],"dysregulated":[53],"MGUS":[55,68,198],"MM,":[57],"while":[58],"c-MYC":[59,100,116,130],"overexpression":[60],"sometimes":[62],"RAS":[63,145],"associated":[66,293],"with":[67,294,323,331,378,415,433,479,492],"to":[69,98,108,150,199,329,346,384,392,429,494,511,523],"MM":[70,167,178,207,373,455],"progression.":[71],"c-MYC,":[72],"because":[73],"its":[75,172,469],"strong":[76],"association":[77],"this":[79,210,219,355],"malignant":[80],"transformation":[81],"it":[83,148,348,473,487,506],"being":[84],"master":[86],"regulatory":[87],"factor":[88],"logical":[91],"therapeutic":[92,96,352,529],"target.":[93,353],"But,":[94],"approach":[97],"target":[99,109,530],"has":[101,446],"not":[102],"been":[103],"successful.":[104],"So":[105,519],"strategy":[107],"either":[110],"upstream":[111],"or":[112,560,578,596,614,633,651,669,687,704],"downstream":[113,127,143],"pathway":[117],"worth":[119],"considering.":[120],"Ornithine":[121],"decarboxylase":[122],"(ODC)":[123],"one":[125],"such":[126],"effector":[128],"regulates":[132,137],"polyamine":[133],"synthesis":[134],"thus":[136],"cell":[138,374,398],"proliferation.":[139],"ODC":[140,162,192,216,232,240,258,269,291,325,333,517,522],"also":[142],"makes":[147],"two":[151,480],"the":[153,177,181,363,436,496],"important":[154],"oncogenes":[155],"involved":[156],"To":[159,297],"know":[160],"whether":[161],"plays":[163],"role":[165,341],"pathogenesis,":[168],"we":[169,187,267,302,310,344,357,520],"looked":[170,256],"into":[171],"gene":[173],"expression":[174,193,217,259,270,292,326,334],"profile":[175,450],"patients.":[179],"In":[180],"Mayo":[182,535],"cohort":[183,211,308],"100":[185],"patients":[186,208,322,330,456,513],"found":[188,202,426],"significant":[189,203],"difference":[190,205,221],"as":[194,327,349],"disease":[195],"progresses":[196],"from":[197,209,390],"We":[201,369,407,425,440,504],"survival":[204,220,229,315,320],"were":[213,230],"divided":[214],"by":[215],"was":[222,438],"more":[223],"pronounced":[224],"non-hyperdiploid":[226],"group":[227,305],"(median":[228],"for":[231,239,376,468,545],"<":[233],"1":[234,242],"-":[235,243],"66":[236],"mo":[237],"vs":[238],">":[241],"29.5":[244],"mo,":[245],"Figure":[246],"1A)":[247],"known":[251,274],"poor":[252,278,295,339],"prognostic":[253,279,340,526],"group.":[254],"When":[255],"at":[257],"among":[260],"different":[261,372],"TC":[262],"classes":[263],"MMRC":[265],"dataset,":[266],"find":[268],"significantly":[271],"higher":[272,290],"high":[275,332,516],"risk":[276],"groups":[280],"4p16":[281],"MAF":[283],"than":[284],"other":[285],"groups.":[286],"These":[287],"findings":[288],"suggest":[289,442],"survival.":[296],"further":[298,408],"strengthen":[299],"our":[300],"observation,":[301],"analyzed":[303],"TT3":[304],"Arkansas":[307],"observe":[311],"prolonged":[312],"event":[313],"free":[314],"(Figure":[316,335],"1B)":[317],"overall":[319],"low":[324],"compared":[328],"1C).":[336],"After":[337],"establishing":[338],"ODC,":[343],"wanted":[345],"test":[347],"potential":[351],"For":[354],"purpose,":[356],"employed":[358],"DFMO":[359,385,395,412],"(Difluromethylornithine)":[360],"enzymatic":[364],"irreversible":[365],"inhibitor":[366],"ODC.":[368],"tested":[370,409],"15":[371],"lines":[375],"proliferation":[377],"DFMO,":[379,444],"majority":[380],"them":[382],"respond":[383],"IC":[387],"50":[388],"ranged":[389],"28uM":[391],"70":[393],"uM.":[394],"generally":[396],"halted":[397],"cylce":[399],"G1S":[401],"had":[403],"cytostatic":[405],"effect.":[406],"efficacy":[410],"combination":[414,437],"standard":[416],"anti-myeloma":[417,482],"agents":[418,483],"lenalidomide,":[419],"bortezomib,":[420,486],"Vorinostat,":[421],"melphalan":[422,434],"dexamethasone.":[424],"these":[427],"combinations":[428],"be":[430,452,490,508,524],"synergistic":[431,475],"except":[432],"where":[435],"antagonistic.":[439],"therefore":[441],"good":[448],"toxicity":[449],"can":[451],"advantageous":[453],"who":[457,514],"relatively":[459],"old":[460],"many":[462],"times":[463],"cannot":[464],"tolerate":[465],"extensive":[466],"chemotherapy":[467],"toxicity.":[470,503],"Moreover":[471],"since":[472],"preclinical":[477],"model":[478],"main":[481],"lenalidomide":[484],"may":[488],"well":[489],"combined":[491],"both":[493],"decrease":[495],"amount":[497],"drug":[499],"needed":[500],"hence":[502],"think":[505],"will":[507],"especially":[509],"beneficial":[510],"those":[512],"have":[515],"levels.":[518],"propose":[521],"marker":[527],"Disclosures":[533],"Chirackal:":[534],"Clinic:":[536],"Patents":[537,563,581,599,617,636,654,672,690],"&":[538,564,582,600,618,637,655,673,691],"Royalties:":[539],"Filed":[540],"professional":[542],"US":[543],"patent":[544],"quantifying":[546],"cellular":[547],"anti-oxidative":[548],"capacity.":[549],"Fonseca:Celgene:":[550],"Consultancy,":[551,569,587,605,624,642,660,678],"Honoraria,":[552,570,588,606,625,643,661,679],"Membership":[553,571,589,607,626,644,662,680,697],"on":[554,572,590,608,627,645,663,681,698],"entity's":[556,574,592,610,629,647,665,683,700],"Board":[557,575,593,611,630,648,666,684,701],"Directors":[559,577,595,613,632,650,668,686,703],"advisory":[561,579,597,615,634,652,670,688,705],"committees,":[562,580,598,616,635,653,671,689],"Royalties,":[565,583,601,619,638,656,674,692],"Research":[566,584,602,620,639,657,675,693],"Funding;":[567,585,603,621,640,658,676,694],"BMS:":[568],"Bayer:":[586],"Onyx/Amgen:":[604],"Binding":[622],"Site:":[623],"Novartis:":[641],"Sanofi:":[659],"Millennium:":[677],"Applied":[695],"Biosciences:":[696],"committees.":[706]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-11-30T00:00:00"}